DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD.
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1672142
Singapore, U0
Position in TMO
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,010,880
+$78,640 QoQ
Shares Held
8,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#916
of 2,605 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. holds $5,363,420 across 2 Diagnostics & Research names. TMO ranks #1 (74.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
8,000 | $4,010,880 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
7,000 | $1,352,540 |
All Filings in TMO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,010,880 | 8,000 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $3,932,240 | 8,000 | Shares | Defined | 2026-05-14 | |
| 2024-12-31 | $1,248,552 | 2,400 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,546,425 | 2,500 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,659,000 | 3,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $988,057 | 1,700 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,326,975 | 2,500 | Shares | Defined | 2024-02-13 | |
| 2020-12-31 | $331,635 | 712 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||